Chris Schott Analyst PerformanceAnalyst at JPMorgan Chase & Co.Chris Schott is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 23 publicly traded companies. Over the past year, Chris Schott has issued 30 stock ratings, including buy, hold, and sell recommendations. While full access to Chris Schott's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Chris Schott's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings106 Last 11 YearsBuy Recommendations69.39% 68 Buy RatingsCompanies Covered23 Unique Companies Ratings Distribution98RatingsDistribution of strong buy, buy, hold, and sell ratings by Chris Schott.RatingPercentageCount Strong Buy0.0%0 ratings Buy69.4%68 ratings Hold27.6%26 ratings Sell3.1%3 ratingsOut of 98 total stock ratings issued by Chris Schott at JPMorgan Chase & Co., the majority (69.4%) have been Buy recommendations, followed by 27.6% Hold and 3.1% Sell.Best & Worst CallsBest Call0000.0%BMYSep 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHCJul 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE52.2% of companies on NYSE12 companiesNASDAQ47.8% of companies on NASDAQ11 companiesChris Schott, an analyst at JPMorgan Chase & Co., currently covers 23 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical23 companies100.0%Chris Schott of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE8 companies34.8%LARGE CAP PHARMA5 companies21.7%MED - DRUGS3 companies13.0%MEDICAL SERVICES2 companies8.7%MED - GENERIC DRG2 companies8.7%MED - OUTP/HM CRE1 company4.3%MED PRODUCTS1 company4.3%MED INSTRUMENTS1 company4.3% Chris Schott's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsZTSZoetis5/8/2026Lower Price Target$81.86$130.00Overweight$0.0000.00% ROIVTRSViatris5/8/2026Boost Price Target$16.84$18.00Neutral$0.0000.00% ROIELANElanco Animal Health5/7/2026Boost Price Target$24.04$30.00Overweight$0.0000.00% ROIRPRXRoyalty Pharma5/7/2026Boost Price Target$50.11$58.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries4/30/2026Boost Price Target$35.03$40.00Overweight$0.0000.00% ROIMRKMerck & Co., Inc.4/6/2026Boost Price Target$120.73$135.00Overweight$0.0000.00% ROIJNJJohnson & Johnson3/5/2026Boost Price Target$238.61$250.00Neutral$0.0000.00% ROIELANElanco Animal Health2/19/2026Boost Price Target$24.97$28.00Overweight$0.0000.00% ROIGILDGilead Sciences2/11/2026Boost Price Target$147.23$160.00Overweight$0.0000.00% ROILLYEli Lilly and Company2/5/2026Boost Price Target$1,035.27$1,300.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. REGNRegeneron Pharmaceuticals2/2/2026Boost Price Target$752.06$950.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries12/16/2025Boost Price Target$30.02$35.00Overweight$0.0000.00% ROIPRGOPerrigo12/15/2025Lower Price Target$12.85$18.00Neutral$0.0000.00% ROILLYEli Lilly and Company11/18/2025Boost Price Target$1,026.30$1,150.00Overweight$0.0000.00% ROIOGNOrganon & Co.11/11/2025Lower Price Target$7.38$12.00Underweight$0.0000.00% ROIPRGOPerrigo11/6/2025Reiterated Rating$15.06$20.00Neutral$0.0000.00% ROITEVATeva Pharmaceutical Industries11/6/2025Boost Price Target$24.41$28.00Overweight$0.0000.00% ROIZTSZoetis11/5/2025Lower Price Target$120.47$200.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories11/4/2025Boost Price Target$716.71$775.00Overweight$0.0000.00% ROIABBVAbbVie11/3/2025Boost Price Target$217.86$260.00Overweight$0.0000.00% ROIGILDGilead Sciences10/31/2025Boost Price Target$119.00$150.00Overweight$0.0000.00% ROIELANElanco Animal Health10/7/2025Upgrade$20.68$24.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries10/3/2025Boost Price Target$20.05$26.00Overweight$0.0000.00% ROIGILDGilead Sciences9/16/2025Boost Price Target$112.54$145.00Overweight$0.0000.00% ROILLYEli Lilly and Company9/16/2025Lower Price Target$748.26$1,050.00Overweight$0.0000.00% ROIAMRXAmneal Pharmaceuticals9/16/2025Boost Price Target$9.79$14.00Overweight$0.0000.00% ROIABBVAbbVie9/16/2025Boost Price Target$217.92$235.00Overweight$0.0000.00% ROIPRGOPerrigo8/7/2025Lower Price Target$22.83$35.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories8/4/2025Boost Price Target$682.78$675.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals6/9/2025Lower Price Target$502.10$800.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries5/12/2025Upgrade$16.94$23.00Overweight$00.0000.00% ROIBIIBBiogen5/5/2025Lower Price Target$123.14$175.00Neutral$000.0000.00% ROIREGNRegeneron Pharmaceuticals3/31/2025Lower Price Target$634.04$1,000.00Overweight$000.0000.00% ROIGILDGilead Sciences3/27/2025Boost Price Target$111.01$130.00Overweight$000.0000.00% ROIAMRXAmneal Pharmaceuticals2/24/2025Upgrade$7.83$12.00Overweight$00.0000.00% ROIGILDGilead Sciences1/29/2025Boost Price Target$93.85$115.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageRoyal Bank Of CanadaJPMorgan Chase & Co.Berenberg BankWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
